Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucocorticoid-Refractory aGVHD”

6 trials

Showing 6 of 6 results

Testing effectiveness (Phase 2)Ended earlyNCT04941404
What this trial is testing

TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)

Who this might be right for
Glucocorticoid-Refractory aGVHD
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 13
Testing effectiveness (Phase 2)Ended earlyNCT01757197
What this trial is testing

Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)

Who this might be right for
Glucocorticosteroid Refractory Acute GVHD
Weill Medical College of Cornell University 2
Testing effectiveness (Phase 2)Ended earlyNCT01530256
What this trial is testing

Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Acute GvHD
CSL Behring 3
Testing effectiveness (Phase 2)Study completedNCT00357084
What this trial is testing

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 53
Very early researchUnknownNCT05094765
What this trial is testing

Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of GI-aGVHD

Who this might be right for
GVHD
Shenzhen Xbiome Biotech Co., Ltd. 15
Testing effectiveness (Phase 2)UnknownNCT00032279
What this trial is testing

Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease

Who this might be right for
Graft-vs-Host Disease
Fred Hutchinson Cancer Center 80

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation